| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | President &CEO | President And CEO
1 company
Usman Nassim is a Director at GYRE. Recent filings cover 7 purchases and 6 sales. Those positions are worth an estimated $11K at current prices.
Our model assigns Usman Nassim a middling insider score of 67/100, based on 7 past trades. Over a 12-month horizon, 85.7% of those trades were profitable, with an average 12-month return of +30.8%.
Usman Nassim's largest disclosed position is in GYRE as Director, worth about $11K. The recent filings there lean toward selling, a net 46,921 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 17, 2015 | GYRE Gyre Therapeutics, Inc. | President &CEO | Buy | 4,000 | $2.00 | $8,000.00 | +5.4% |